Company intelligence / Profile preview
Sinopharm Ruifulai Pharmaceutical
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
Overview
Sinopharm Ruifulai Pharmaceutical is a specialized pharmaceutical manufacturing subsidiary of Sinopharm Modern Pharmaceutical, part of the state-owned China National Pharmaceutical Group (Sinopharm). Based in Tianjin, the company focuses on the production of high-quality finished dosage forms, including tablets, capsules, and granules. Its therapeutic focus primarily covers cardiovascular, anti-infective, and respiratory medicine. The company's product portfolio features widely used generic medications such as amlodipine besylate and azithromycin, produced under strict GMP compliance. As a key production base within the Sinopharm network, it supports both the domestic Chinese healthcare system and international export markets. The facility is recognized as a high-tech enterprise and maintains a strong reputation for quality control and manufacturing efficiency.
- Therapeutic areas
- Infectious DiseasesCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Sinopharm Ruifulai Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinopharm Ruifulai Pharmaceutical.